Medicine formula for eliminating in-vivo enolotoxin
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A bacterial endotoxin and drug technology, applied in antibacterial drugs, drug combinations, pharmaceutical formulations, etc., can solve problems such as endotoxin, poisoning death, fever, etc., to overcome drug resistance, high cure rate, and curative effect. significant effect
Active Publication Date: 2015-07-29
SICHUAN CHENGKANG ANIMAL PHARMA
View PDF3 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
It can control the disease in the early stage of animal disease, but it cannot solve the pathogenic endotoxin released after the dead body of the bacteria disintegrates. The endotoxin in the body exceeds the animal's tolerance, causing the animal to generate heat and eventually lead to poisoning die
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] Formula A: flunixin meglumine 1mg / kg body weight, vitamin C 1mg / kg body weight;
[0033] Formula B: ceftiofur sodium 2mg / kg body weight, enrofloxacin 1.5mg / kg body weight;
[0034] Described flunixin meglumine is the injection of 0.05g / ml, and described vitamin C is the injection of 0.1g / ml, and described enrofloxacin is the injection of 0.05g / ml, and described ceftiofur sodium is frozen Dry powder injection.
[0035] Formulas A and B were prepared respectively according to the above doses, and the formulas A and B were intramuscularly injected on both sides of the pig body respectively.
Embodiment 2
[0037] Formula A: flunixin meglumine 1.5mg / kg body weight, vitamin C 2mg / kg body weight;
[0038] Formula B: ceftiofur sodium 3mg / kg body weight, enrofloxacin 2mg / kg body weight;
[0039] Described flunixin meglumine is the injection of 0.05g / ml, and described vitamin C is the injection of 0.1g / ml, and described enrofloxacin is the injection of 0.05g / ml, and described ceftiofur sodium is frozen Dry powder injection.
[0040] Formulas A and B were prepared respectively according to the above doses, and the formulas A and B were intramuscularly injected on both sides of the pig body respectively.
Embodiment 3
[0042] Formula A: flunixin meglumine 2.5mg / kg body weight, vitamin C 3mg / kg body weight;
[0043] Formula B: ceftiofur sodium 5mg / kg body weight, enrofloxacin 2.5mg / kg body weight;
[0044] Described flunixin meglumine is the injection of 0.05g / ml, and described vitamin C is the injection of 0.1g / ml, and described enrofloxacin is the injection of 0.05g / ml, and described ceftiofur sodium is frozen Dry powder injection.
[0045] Formulas A and B were prepared respectively according to the above doses, and the formulas A and B were intramuscularly injected on both sides of the pig body respectively.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicine formula for eliminating in-vivo enolotoxin. The medicine formula comprises a formula A and a formula B, wherein the formula A comprises raw materials in parts by weight as follows: 1-4 parts of flunixin meglumine and 1-6 parts of vitamin C; the formula B comprises raw materials in parts by weight as follows: 2-8 parts of ceftiofur sodium and 1.5-5 parts of enrofloxacin, wherein flunixin meglumine is an injection with a specification of 0.05g/ml, the vitamin C is an injection with a specification of 0.1g/ml, enrofloxacin is an injection with a specification of 0.05g/ml, and ceftiofur sodium is a freeze-dried powder injection. The medicine formula can effectively eliminate enolotoxin causing diseases to animals, has high sensitivity to pathogenic bacteria such as escherichia coli, infectious actinobacillus pleuropneumoniae, haemophilus parasuis and the like, can be used for effectively treating diseases such as hydropsy, infectious pleuropneumonia, fevering, loss of appetite and the like caused by the pathogenic bacteria and has remarkable curative effects.
Description
technical field [0001] The invention relates to the preparation technology of veterinary medicine, in particular to a medicine prescription for removing bacterial endotoxin in the body. Background technique [0002] Bacterial endotoxin, called Enolotoxin in English, is a unique structure on the cell wall of G-bacteria. Endotoxin is an exogenous pyrogen, which can activate neutrophils, etc., to release an endogenous heat The original substance acts on the thermoregulatory center to cause fever. Medicine has proved that endotoxin has the following biological activities: 1. Pyrogenicity; 2. Fatal toxicity; 3. Leukopenia; 4. Shwartzman reaction; 8. Stimulate mitosis of lymphocytes; 9. Induce specific resistance against infection; 10. Necrosis of tumor cells. In the field of veterinary medicine, pathogenic bacteria such as Actinobacillus pleuropneumoniae, Haemophilus parasuis, Salmonella typhi, Mycobacterium tuberculosis, Shigella, Escherichia coli and other pathogenic bacteria...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more